Brief: Elicera Therapeutics Q3 Adjusted EPS Sek 0.01
14/11/2025 07:39
Nov 14 (Reuters) - Elicera Therapeutics AB ELIC.ST: Q3 ADJUSTED EPS SEK 0.01 REPORTS Q3 2025 OPERATING LOSS OF SEK 146,689 Source text: ID:nWkr5xHBqw Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent